![]() ![]() A multi-component cognitive-behavioral intervention for sleep disturbance in veterans with PTSD: a pilot study. ( References marked with an asterisk indicate studies includedthe present meta-analysis). Cognitive behavioral therapy for patients with primary insomnia or insomnia associated predominantly with mixed psychiatric disorders: a randomized clinical trial. ![]() *Edinger JD, Olsen MK, Stechuchak KM, et al. Brief behavioral therapy for refractory insomnia in residual depression: an assessor-blind, randomized controlled trial. *Watanabe N, Furukawa TA, Shimodera S, et al. A meta-analysis on the treatment effectiveness of cognitive behavioral therapy for primary insomnia. Identifying effective psychological treatments for insomnia: a meta-analysis. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. An American Academy of Sleep Medicine review. Nonpharmacologic treatment of chronic insomnia. Morin CM, Hauri PJ, Espie CA, Spielman AJ, Buysse DJ, Bootzin RR. International classification of sleep disorders-third edition (ICSD-3). 1997 31:333–46.Īmerican Academy of Sleep Medicine (AASM) (editor). Prevalence of DSM-IV diagnostic criteria of insomnia: distinguishing insomnia related to mental disorders from sleep disorders. Comorbidity of chronic insomnia with medical problems. ![]() Taylor DJ, Mallory LJ, Lichstein KL, Durrence HH, Riedel BW, Bush AJ. Chronic insomnia as a risk factor for developing anxiety and depression. Zammit GK, Weiner J, Damato N, Sillup GP, McMillan CA. The morbidity of insomnia uncomplicated by psychiatric disorders. Weissman MM, Greenwald S, Nino-Murcia G, Dement WC. The direct and indirect costs of untreated insomnia in adults in the United States. Epidemiologic study of sleep disturbances and psychiatric disorders. An epidemiological study of insomnia among the Japanese general population. Kim K, Uchiyama M, Okawa M, Liu X, Ogihara R. References marked with an asterisk indicate studies included the present meta-analysis CBT-I is an effective treatment for reducing the severity of insomnia and important disease-related symptoms of comorbid insomnia. ![]() At follow-up, the effect sizes of CBT-I were large for all outcome variables, but several large and significant heterogeneities were confirmed. Analysis revealed that the effect sizes of the treatment were medium to large for important disease-related symptoms ( g = 0.60), insomnia severity ( g = 0.94), subjective and objective sleep onset latency ( g = 0.65 and g = 0.51, respectively), subjective waking after sleep onset ( g = 0.61), subjective and objective sleep efficiency ( g = 0.83 and g = 0.48, respectively), and sleep quality ( g = 0.80), but was small for health-related QoL ( g = 0.34) compared with a control group. Effect sizes were computed with Hedges’ g, and study quality was evaluated using the Jadad scale. A comprehensive literature search identified 30 randomized controlled trials (RCT) that were eligible for inclusion in the final analyses. To fill this gap in the literature, we conducted a meta-analysis on the efficacy of CBT-I in the remediation of insomnia severity, important disease-related symptoms, and quality of life (QoL) in comorbid insomnia. Although cognitive behavioral therapy (CBT-I) has been recommended for the treatment of insomnia comorbid with psychiatric disorders and medical diseases, the effectiveness of CBT-I in such cases remains to be established. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |